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Castleman's disease (CD) is a lymphoproliferative disease. Two
histological subtypes of CD are hyaline-vascular and plasma cell
variants. CD is classiﬁed clinicoradiologically into unicentric
(localized) type and multicentric (diffuse) type according to the
extent of spreading of the disease. Initial CD diagnosis is usually
based on imaging ﬁndings; further conﬁrmation is made by exci-
sional biopsy and histopathological evaluation.
2. Case report
A 57-year-old female patient was admitted to hospital for
further consultation regarding a left suprarenal tumor which was
found incidentally during a physical check-up 6 years previously.
This left suprarenal tumor showed an increase in size in a recent
follow-up computed tomography (Fig. 1). On admission, physical
and laboratory examinations were unremarkable. Following the
initial examination, magnetic resonance imaging (MRI) revealed a
left suprarenal tumor (Fig. 2). Robotic-assisted laparoscopic left-
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enlarged regional retroperitoneal lymph nodes. The pathological
report revealed CD in the retroperitoneal lymph nodes, and normal
left-adrenal gland. The postoperative course was uneventful. The
patient was discharged in a stable condition. Outpatient follow up
was recommended.
3. Discussion
CD was ﬁrst reported by Castleman and Towne1 in 1954. The
cause of CD is still unknown. Two histological subtypes of CD are
hyaline-vascular and plasma cell varaints.2 CD is classiﬁed clin-
icoradiologically into unicentric (localized) type and multicentric
(diffuse) type according to the extent of spreading of the disease.3,4
CD may occur in any site where lymph nodes exist. Approximately
70% of CD occurs in the thorax (10e15% each in the neck and
abdomen), retroperitoneum, and pelvis.2,5 The hyaline-vascular
variant accounts for approximately 90% of unicentric CD and is
characterized by lymphoid follicular hyperplasia and vascular
proliferation in the interfollicular region. The plasma cell variant is
seen in both unicentric and multicentric forms of CD, and com-
prises approximately 10% of unicentric CD. It is characterized by
sheets of polyclonal plasma cells within the interfollicular zone and
more variable vascular proliferation compared to the hyaline-
vascular variant. Both HIV and HHV-8 have been associated with
CD.6 The majority of multicentric CD is associated with an immu-
nodeﬁciency state, such as HIV and HHV-8 infection.7 Unicentric CD
is usually seen in patients <30 years of age. It tends to affect nodal
groups, and causes symptoms and signs from lymphadenopathy.
Multicentric CD is usually associated with HIV and HHV-8 co-
infection, and hence it has systemic symptoms and signs such as
loss of appetite, weight loss, night sweats, and fatigue.
Initial CD diagnosis is usually based on imaging ﬁndings, and
further conﬁrmation is made by excisional biopsy and histopath-
ological evaluation. CT generally shows a well-circumscribed mass
of soft tissue attenuation. Calciﬁcation is infrequent and can include
punctate, coarse, peripheral, and arborizing patterns. Smaller
masses show homogeneous contrast enhancement, and larger
masses show heterogeneous contrast enhancement.8,9 Differential
diagnosis varies according to the location such as paragangliomas,
pheochromocytomas, neurogenic tumors, sarcomas, andan LLC. All rights reserved.
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Fig. 1. Retroperitoneal Castleman's disease. (A) Axial noncontrast computed tomography reveals a well-deﬁned mass with density identical to the muscle in the left suprarenal
region. (B) Axial contrast-enhanced computed tomography reveals marked contrast enhancement of this mass.
Fig. 2. Retroperitoneal Castleman's disease. (A) Axial and coronal noncontrast T1-weighted magnetic resonance image (MRI) reveals a well-deﬁned mass with signal intensity
identical to the muscle in the left suprarenal region. (B) Axial and coronal noncontrast T2-weighted MRI reveals high signal intensity of this mass. (C) Axial and coronal contrast-
enhanced T1-weighted MRI reveals marked contrast enhancement of this mass.
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muscle on T1-weighted images and hyperintense signals on T2-
weighted images, and marked contrast enhancement.10
Treatment is surgical resection.Conﬂicts of interest
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